Announced Wed, 1 Apr · 18:04 IST
Routine SEBI Reg 74(5) compliance certificate for Q4 FY26
Compliance View source PDF
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.4%1-day move
₹817.00
prior close
₹815.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2-1.1-1.3-1.0+4.4+5.7+7.2+6.7+8.8+11.4+16.8+14.1+19.0+19.0
Up moveDown movePending
AI summary
Jubilant Pharmova has submitted to the exchanges a quarterly confirmation certificate from its Registrar and Share Transfer Agent, Alankit Assignments Limited, under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The certificate confirms that physical share certificates received for dematerialization have been listed, verified, mutilated/cancelled, and the depository recorded as the registered owner.
Likely market impact
Routine regulatory compliance filing; no impact on shareholders, operations, or stock price.